Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies
mRNA translational control by CPEBs is reactivated in cancer. Here, the authors show that the insertion of CPE regulatory sequences in the 3′ UTR of the E1A viral gene induces oncoselectivity, with oncolytic potency in cancer cells but attenuated toxicity in normal tissues.
Guardado en:
Autores principales: | Eneko Villanueva, Pilar Navarro, Maria Rovira-Rigau, Annarita Sibilio, Raúl Méndez, Cristina Fillat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e057e2ac80034205b539e6796fe42a12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
por: RaeAnna Wilson, et al.
Publicado: (2016) -
Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape
por: Kristin C. Hicks, et al.
Publicado: (2021) -
Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection
por: Anil Pant, et al.
Publicado: (2021) -
Regulation of Viral Restriction by Post-Translational Modifications
por: Célia Chamontin, et al.
Publicado: (2021) -
Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment
por: Sandra S. Ring, et al.
Publicado: (2021)